Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
6
Neutral
3
Bullish
5
Bearish
6
Neutral
15
Bullish
25
Bearish
0
Neutral
12
Bullish
20
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Market Cap
₹ 72 Cr
P/E
18.97
Pharmaceuticals
Pharmaceuticals - Indian - Bulk Drugs
72 Cr
Low Risk
19.0
59.2
0.1
1.9
126.00
75.21
Sales CAGR
1Y
56.21%
3Y
37.66%
5Y
—
10Y
—
Profit CAGR
1Y
58.44%
3Y
226.59%
5Y
—
10Y
—
ROE
TTM
—
3Y
36.33%
5Y
—
10Y
—
ROCE
TTM
—
3Y
46.23%
5Y
—
10Y
—
Performance
UNDER PERFORMER
Valuation
REASONABLE
Growth
EXCEPTIONAL
Profitability
MODERATE MARGIN
Technicals
Bullish
Risk
MODERATE RISK